CHI3L1 and Hepatic fibrosis: For the untreated cirrhotic patients, liver fibrosis measured as the CHI3L1 level increased to 198.26 (264.90) at the week 96 follow-up vs. 158.17 (177.14) at the baseline, which is an approximately 25% increase in approximately 2 years (96 weeks).